Copyright
©The Author(s) 2023.
World J Diabetes. Jun 15, 2023; 14(6): 656-679
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.656
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.656
Table 1 List of various circulating microRNAs reported in diabetes mellitus individuals
| Mechanism/pathway (diabetes type) | Expression of miRNAs | Ref. |
| Endothelial dysfunction (T2DM) | ↑miR-28-3p | [87] |
| ↓miR-24 | ||
| ↓miR-21 | ||
| ↓miR-20b | ||
| ↓miR-15a | ||
| ↓miR-126 | ||
| ↓miR-191 | ||
| ↓miR-197 | ||
| ↓miR-223 | ||
| ↓miR-320 | ||
| ↓miR-486 | ||
| ↓miR-150 | ||
| ↓miR-29b | ||
| ↓miR-107 | ||
| ↓miR-132 | ||
| ↓miR-144 | ||
| Glucose metabolism (T2DM) | ↑miR-9 | [88] |
| ↑miR-29a | ||
| ↑miR-30d | ||
| ↑miR-34a | ||
| ↑miR-124a | ||
| ↑miR-146a | ||
| ↑miR-375 | ||
| Inflammation (T2DM) | ↓miR-146a | [89] |
| Glucose metabolism (T2DM) | ↑miR-27a | [90] |
| ↑miR-320a | ||
| Glucose metabolism (T2DM) | ↓miR-126 | [91-93] |
| Inflammation (T2DM) | ↓miR-103b | [94] |
| Inflammation (T2DM) | ↓miR-126-3p | [95] |
| ↓miR-21-5p | ||
| Inflammation (T2DM) | ↓miR-126 | [96] |
| Endothelial dysfunction (T2DM) | ↓miR-126 | [97] |
| ↓miR-26a | ||
| Glucose metabolism (T2DM) | ↓miR-21 | [98] |
| Inflammation (T2DM) | ↓miR-126-3p | [99] |
| Endothelial dysfunction (T2DM) | ↓miR-24 | [100] |
| Platelet reactivity (T2DM) | ↓miR-223 | [101] |
| ↓miR-26b | ||
| ↓miR-126 | ||
| ↓miR-140 | ||
| Glucose metabolism (T2DM) | ↑miR-375 | [102] |
| ↑miR-9 | ||
| Glucose metabolism (T2DM) | ↑miR-30a-5p | [103] |
| ↑miR-150 | ||
| ↓miR-103 | ||
| ↓miR-28-3p | ||
| ↓miR-29a | ||
| ↓miR-9 | ||
| ↓miR-15a | ||
| ↓miR-126 | ||
| ↓miR-145 | ||
| ↓miR-375 | ||
| ↓miR-223 | ||
| ↓miR-133 | ||
| ↓miR-107 | ||
| Endothelial dysfunction (miR-126); hypoxia (miR-210) (T2DM) | ↓miR-126 | [104] |
| ↑miR-210 | ||
| Angiogenesis (T2DM) | ↑miR-193b-3p | [105] |
| ↑let-7i-5p | ||
| ↑miR-199a-3-5p | ||
| ↑miR-26b-5p | ||
| ↑miR-30b-5p | ||
| ↑miR-374a-5p | ||
| ↑miR-20a-3p | ||
| ↑miR-26a-5p | ||
| ↑miR-30c-5p | ||
| ↓miR-409-3p | ||
| ↓miR-95-3p | ||
| Apoptosis (T1DM) | ↑miR-21 | [106,107] |
| ↓miR-23a-3p | [108] | |
| ↓miR-23b-3p | ||
| ↓miR-149-5p | ||
| Inflammation (T1DM) | ↑miR-101a | [109] |
| ↑miR-30b | ||
| -cell dysfunction (T1DM) | ↑miR-106b-5p | [110,111] |
| ↑miR-222-3p | ||
| ↑miR-181a | ||
| T-cell dysfunction (T1DM) | ↑miR-26a | [112] |
| ↑miR-98 | [113] | |
| ↑miR-23b | ||
| ↑miR-590-5p | ||
| -cell lymphopoiesis (T1DM) | ↑miR-34a | [114] |
| DNA damage checkpoint (T1DM) | ↑miR-200 | [115] |
| Apoptosis (T1DM) | ↓miR-144 | [116] |
| Autoimmune imbalance (T1DM) | ↓miR-146a | [117] |
| MODY | ↑miR-103 | [118] |
| MODY | ↑miR-224 | |
| Glucose metabolism (GDM) | ↑miR-222 | [119] |
| ↑miR-98 | [120] | |
| ↑miR-518d | [121] | |
| ↑miR-340 | [122] | |
| ↑miR-130b, miR148a | [123] | |
| -cell dysfunction (GDM) | ↑miR-33a-5p | [124] |
| ↑miR-330-3p | [125] | |
| ↓miR-494 | [126] | |
| ↓miR-96 | [127] | |
| ↓miR-221 | [128] |
Table 2 Studies on polygenic risk score for type 1 diabetes mellitus and type 2 diabetes mellitus
| Diabetes type | SNPs | AUC for PRS | Ethnicity | Ref. |
| T1DM | 41 | 0.87 | Caucasian | [140] |
| T1DM | 30 | 0.88 | Caucasian | [141] |
| T1DM + T2DM | 99 | 0.89 | Caucasian | |
| T1DM | 32 | 0.86 | Caucasian | [142] |
| T1DM | 32 | 0.90 | Caucasian Hispanic | |
| T1DM | 32 | 0.75 | African-American | |
| T1DM | 32 | 0.92 | Asian-American | |
| T1DM | 67 | 0.93 | Caucasian | [143] |
| T2DM | 3 | 0.58 | Caucasian | [144] |
| T2DM | 18 | 0.80 | Caucasian | [136] |
| T2DM | 16 | 0.75 | Caucasian | [134] |
| T2DM | 18 | 0.91 | Caucasian | [135] |
| T2DM | 22 | 0.74 | Caucasian | [145] |
| T2DM | 62 | 0.91 | Caucasian United States population | [146] |
| T2DM | 1000 | 0.79 | Caucasian | [147] |
| T2DM | 4 | 0.67 | African | [148] |
| T2DM | 7 million | 0.73 | Caucasian | [149] |
Table 3 Polygenic risk scores studies for gestational diabetes mellitus
Table 4 List of phytochemicals used in the prevention and treatment of diabetes and its complications
| Phytochemical | Source | Outcomes | Ref. |
| Curcumin | Curcuma longa | ↑Insulin sensitivity, ↓blood glucose levels, and hypoglycemia | [180] |
| Rutin | Buckwheat (Fagopyrum esculentum) | ↓Hepatic glucose production, ↑glucose tolerance | [181] |
| Resveratrol | Grapes, plums, peanuts, nuts, red wine | Improved insulin signaling, ↑glucose-mediated insulin secretion | [182] |
| Quercetin | Apples, black tea, berries, capers, red wine, onions | ↑Glucose uptake, ↓hepatic glucose production | [182,183] |
| Genistein | Legumes | Improved lipid glucose metabolism and ↓fasting glucose | [184] |
| Hesperidin | Orange, lemon | ↑Glucose uptake, ↓HbA1c, ↓oxidative stress | [185] |
| Naringin | Skin of grapefruit and orange | ↓Hepatic glucose production, ↓oxidative stress, ↑glucose uptake | [185] |
| Naringenin | Citrus fruits, tomatoes, cherries, grapefruit, cocoa | ↑Glucose uptake, ↓glucose intolerance and reduced blood glucose levels | [186] |
| Vitamin A, D, and E | Eggs, yellow, red, and green (leafy) vegetables, such as spinach, carrots, sweet potatoes and red peppers. yellow fruit, such as mango, papaya and apricots | ↓Glucose intolerance, ↓hyperglycemia | [182] |
| Fisetin | Strawberry, apple, persimmon, grape, onion, and cucumber | ↓Hepatic glucose and ↑glucose metabolism | [187] |
| Flavonoids | Coffee, guava tea, whortleberry, olive oil, propolis, chocolate, and cocoa | ↓Glucose absorption, inhibition of advanced glycation end products | [188] |
| Isoflavones | Soybean | Improves glucose metabolism | [189] |
| Catechins | Tea leaves and red wine | Promote insulin sensitivity | [190] |
| Hydroxycinnamic acids | Fruits and vegetables, especially the outer part of ripe fruits | Promote glucokinase activity | [191] |
| Caffeoylquinic | Potatoes, eggplants, peaches, prunes, and coffee beans | Promote insulin response | [192] |
| Anthocyanins and anthocyanidins | Berries, eggplants, avocado, oranges, olives, red onion, fig, sweet potato, mango, and purple corn | Promote blood glucose regulation | [193] |
| Stillbenoids | Grapevine, berries, and peanuts | Promote pancreatic -cell and hepatoprotective activity | [194] |
- Citation: Goyal S, Rani J, Bhat MA, Vanita V. Genetics of diabetes. World J Diabetes 2023; 14(6): 656-679
- URL: https://www.wjgnet.com/1948-9358/full/v14/i6/656.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i6.656
